These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32823452)

  • 21. Tofacitinib in kidney transplantation.
    Wojciechowski D; Vincenti F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1193-9. PubMed ID: 23841583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis.
    Itoh I; Kasuno K; Yamamoto C; Takahashi N; Shimizu H; Ojima T; Hayashi S; Kimura H; Iwano M
    Intern Med; 2020 Mar; 59(6):817-821. PubMed ID: 31813912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Episcleritis and scleritis: clinical features and treatment results.
    Jabs DA; Mudun A; Dunn JP; Marsh MJ
    Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tofacitinib for the treatment of psoriasis.
    Galluzzo M; D'Adamio S; Servoli S; Bianchi L; Chimenti S; Talamonti M
    Expert Opin Pharmacother; 2016 Jul; 17(10):1421-33. PubMed ID: 27267933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excellent response to tofacitinib treatment in a patient with alopecia universalis.
    Erduran F; Adışen E; Aksakal AB
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):47-49. PubMed ID: 28632888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.
    Haynes D; Topham C; Hagstrom E; Greiling T
    Australas J Dermatol; 2020 Feb; 61(1):e108-e110. PubMed ID: 31318041
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of multiple immunosuppressive agents in recalcitrant ACANTHAMOEBA scleritis.
    Igras E; Murphy C
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
    Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC
    Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea.
    Lee MY; Park SK; Park SY; Byun JH; Lee SM; Ko SK; Lee EK
    Clin Ther; 2015 Aug; 37(8):1662-76.e2. PubMed ID: 26243076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [JAK Inhibitors in Rheumatology].
    Witte T
    Dtsch Med Wochenschr; 2019 Jun; 144(11):748-752. PubMed ID: 31163474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of refractory dermatomyositis responsive to tofacitinib.
    Paik JJ; Christopher-Stine L
    Semin Arthritis Rheum; 2017 Feb; 46(4):e19. PubMed ID: 27642158
    [No Abstract]   [Full Text] [Related]  

  • 32. Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology.
    Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
    Curr Med Chem; 2017 May; 24(11):1158-1167. PubMed ID: 28088907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.
    Vyas D; O'Dell KM; Bandy JL; Boyce EG
    Ann Pharmacother; 2013 Nov; 47(11):1524-31. PubMed ID: 24285764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
    Vieira MC; Zwillich SH; Jansen JP; Smiechowski B; Spurden D; Wallenstein GV
    Clin Ther; 2016 Dec; 38(12):2628-2641.e5. PubMed ID: 27889300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodular anterior scleritis associated with Berger's disease.
    Constancio EG; Alves DLS; Mello LGM; Silva LBD; Saraiva FP; Polido J; Cabral T
    Arq Bras Oftalmol; 2021; 84(1):74-77. PubMed ID: 33470345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
    van der Heijde D; Strand V; Tanaka Y; Keystone E; Kremer J; Zerbini CAF; Cardiel MH; Cohen S; Nash P; Song YW; Tegzová D; Gruben D; Wallenstein G; Connell CA; Fleischmann R;
    Arthritis Rheumatol; 2019 Jun; 71(6):878-891. PubMed ID: 30666826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy.
    Yoshida M; Yokokura S; Kunikata H; Takada N; Maruyama K; Toyokawa M; Kashio K; Kaku M; Nakazawa T
    Int Ophthalmol; 2018 Apr; 38(2):841-847. PubMed ID: 28429128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scleritis, clinical features, etiologies and treatment: a case series of 32 patients].
    Leal C; Le Roux K; Rahmi A; Varron L; Broussolle C; Denis P; Kodjikian L; Sève P
    Rev Med Interne; 2014 Aug; 35(8):491-7. PubMed ID: 24210266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis.
    Murthy SI; Shah S; Bagga B; Dudam R
    Indian J Ophthalmol; 2020 Sep; 68(9):1981-1983. PubMed ID: 32823449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.